Druggable Lipid Signaling Pathways 2020 ORIGINAL PDF

Druggable Lipid Signaling Pathways 2020 ORIGINAL PDF

12 $

AUTHORS: Yasuyuki Kihara
Category:

Druggable Lipid Signaling Pathways 2020 ORIGINAL PDF

This edited work presents a series of reviews focusing on Druggable Lipid Signaling Pathways. It enables researchers in both academic institutions and industry as well as physicians to understand historical aspects of lipid signaling and future directions of drug discovery targeting lipid signaling pathways. This book provides 9 pathways including acyltransferases, prostanoids, leukotrienes, epoxy fatty acids, sphingolipids, lysophospholipids, endocannabinoids, phosphoinositides, and lipid GPCRs.

Readers will discover the importance of each lipid signaling pathway that contributes to broad range of diseases including neurological and neuropsychiatric diseases, pain, metabolic syndromes, cardiovascular diseases, cancer, dermatological diseases, fibrosis, inflammation, etc. Also, readers will recognize that many drugs targeting lipid signaling have been clinically used. Drugs currently under development are also discussed in each chapter, which includes some information about clinical trials and strategic drug designs.

AUTHORS: Yasuyuki Kihara

PAGES: 260

YEAR: 2020

PUBLICATION: Springer, Cham

LANGUAGE: English

Related Products